US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist
  • 21.250
  • +0.070+0.33%
Close Jan 8 16:00 ET
  • 21.190
  • -0.060-0.28%
Post 20:01 ET
3.06BMarket Cap-7.70P/E (TTM)

Denali Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Denali Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 9.179M--
--2024/Q30.000 / 8.357M--
--2024/Q20.000 / 10.773M--
--2024/Q10.000 / 13.022M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 9.179M--
--2024/Q30.000 / 8.357M--
--2024/Q20.000 / 10.773M--
--2024/Q10.000 / 13.022M--

Unlock Free Earnings Estimates

Denali Therapeutics Earnings Reports

  • Denali Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:22 ET

  • Denali Therapeutics | 8-K: Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 6, 2024 16:21 ET

  • Denali Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 1, 2024 06:57 ET

  • Denali Therapeutics | 8-K: Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

    Aug 1, 2024 06:51 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Collegium Pharmaceutical
    COLL
    +14.41%
    eBay
    EBAY
    +9.86%
    Halozyme Therapeutics
    HALO
    +5.02%
    SilverCrest Metals
    SILV
    +4.63%
    Workday
    WDAY
    +2.01%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 7, 2025

    Strong Buy

    • Buy

      92.86%

    • Hold

      7.14%

    • Sell

      0.00%

    Price Target

    No Data